Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2011
At a glance
- Drugs Mosapride (Primary)
- Indications Irritable bowel syndrome
- Focus Pharmacodynamics
- 01 Aug 2011 Results published in the Neurogastroenterology and Motility.
- 05 Nov 2010 New trial record.